
Hyundai Bioscience launches Phase II clinical trial of Covid-19 drug
CP-COV03 is similar to the human efficacy test of penicillin conducted in 1941, in several ways.
CP-COV03 is similar to the human efficacy test of penicillin conducted in 1941, in several ways.
Sabizabulin was found to be safe and well-tolerated without any treatment-associated adverse events reported in the trial.
Ambrx expects to commence subject enrolment in the ARX788 arms in May this year.
In the six-month follow-up assessment, Evusheld reduced symptomatic Covid-19 development risk by 83% versus placebo.